Andrew Carrel, PhD

Medical Strategy | Real World Evidence Generation | Rare Disease | Nephrology | Hematology | Neurology | Psychiatry

United States

About

Experience

  • Associate Medical Director, Medical Strategy and Evidence Generation at Biogen
    May 2026 - Present · 2 mos

  • Apellis Pharmaceuticals (Full-time · 6 yrs 1 mo)
    • Associate Director, Medical Affairs
      Jul 2024 - May 2026 · 1 yr 11 mos

    • Medical Science Liaison
      May 2020 - Jul 2024 · 4 yrs 3 mos

  • Sage Therapeutics (3 yrs)
    • Senior Medical Science Liaison
      Jul 2019 - Apr 2020 · 10 mos

    • Medical Science Liaison
      May 2017 - Jul 2019 · 2 yrs 3 mos

  • Medical Science Liaison at Lundbeck
    Apr 2016 - May 2017 · 1 yr 2 mos

  • Post-doctoral research fellow at University of Colorado Anschutz Medical Center
    Sep 2012 - Apr 2016 · 3 yrs 8 mos

    My current research focuses on the molecular, cellular, and neurophysiological mechanisms that cause the development of epilepsy. My main focus is pre-clinical drug development for potential new anti-epileptic drugs.